Share

Clinical Studies (1)

  • Drysdale 2 : Study aims to assess the real-world use and outcomes of sotrovimab treatment in Belgium among patients with COVID-19 at high risk of developing severe disease

Study Data

  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to